Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 5 of 5 citing Sacu: Reduced fluence versus standard photodynamic therapy in combination with intravitreal.... (0.09 sec) 

A randomised trial of bevacizumab and reduced light dose photodynamic therapy …


MJ Potter, CC Claudio, SM Szabo - British Medical Journal, 2009 - bjo.bmj.com
Online First articles must include the digital object identifier (DOIs) and date of initial
publication. establish publication priority; they are indexed by PubMed from initial
publication. Citations to may be posted when available prior to final publication). Online ...
Cited by 1 - Related articles - All 3 versions

A randomised trial of bevacizumab and reduced


MJ Potter, CC Claudio, SM Szabo - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.155531 published online June 10, 2009 Br J
Ophthalmol Michael J Potter, Cheryl C Claudio and Shelagh M Szabo macular
degeneration: The VIA study light dose photodynamic therapy in age ...
Related articles

Journal List> J Korean Ophthalmol Soc> v. 50 (9); Sep 2009


JK Chang, SW Kim, JR Oh, K Huh - J Korean Ophthalmol Soc, 2009 - synapse.koreamed.org
The author reviewed the charts of 20 patients (22 eyes) who underwent PDT for chronic central
serous chorioretinopathy. All 22 eyes were treated using an irradiance of 300 mW over 83 second
(25 J/cm 2 ). Postoperative evaluation included improvements in visual acuity, ...
Related articles - Cached - All 2 versions

Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der …


M Stur - Spektrum der Augenheilkunde, 2008 - Springer
Zusammenfassung. Nach Einführung der intravitrealen Therapie ist es zu einem deutlichen Rückgang
der Anwen- dung der photodynamischen Therapie (PDT) mit Verteporfin gekommen, weil die
Resultate nach PDT schlechter sind als nach intravitrealer Applikation von Bevacizumab ...
Related articles

[PDF] 만성 중심장액맥락망막병증에서절반 에너지를 적용한 광역학치료의 효과


장문희, 김성우, 오재령, 허걸, 적인, 암점이 … - J Korean Ophthalmol …, 2009 - pdf.medrang.co.kr
목적: 만성 중심장액맥락망막병증 환자에서 레이저 강도를 반으로 감소시켜 시행한 광역학치료의
효과에 대해 알아보고자 하였다. 대상과 방법: 2007년 8월부터 2008년 10월까지 만성 중심장액맥락망막병증으로
진료하였던 환자 중 절반 에너지를 적용한 광역학치 료를 받고 3개월 이상 경과 관찰이 ...
Related articles - View as HTML - All 4 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google